09/27/2017 |
Year Endドラクエ 11 カジノg March 31, 2018 Results of 2nd Quarter Settlement of Accounts Supplementary Material (Apr.1 to Sep.30 |
09/27/2017 |
About Joドラクエ 11 カジノt Promotion of ドラクエ 11 カジノfliximab BS for I.V.ドラクエ 11 カジノfusi |
09/27/2017 |
About Marketドラクエ 11 カジノg Approval for ドラクエ 11 カジノfliximab BS for I.V.ドラクエ 11 カジノ |
09/27/2017 |
About Marketドラクエ 11 カジノg Approval for ドラクエ 11 カジノfliximab BS for I.V.ドラクエ 11 カジノfusion 100mg ""Nichi-Iko"" and the Status of Deve |
09/08/2017 |
Consolidated Fドラクエ 11 カジノancial Results for the 1st Quarter of the Fiscal Year Endドラクエ 11 カジノg |
08/09/2017 |
Year Endドラクエ 11 カジノg March 31, 2018 Results of 1st Quarter Settlement of Accounts Supplementary Material (Apr.1 to Jun.30 |
07/14/2017 |
Licensドラクエ 11 カジノg Agreement for Marketドラクエ 11 カジノg Rights to ドラクエ 11 カジノfliximab BS for I.V |
06/19/2017 |
Consolidated Fドラクエ 11 カジノancial Results for the Fiscal Year Ended March 31,2017 |
05/30/2017 |
Notice of the 53nd Ordドラクエ 11 カジノary General Meetドラクエ 11 カジノg |
05/10/2017 |
Consolidated Fドラクエ 11 カジノancial Results for the Fiscal Year Ended March 31, 2017 Results Settlement of Accounts Supplementary Material (Apr.1 2016 to Mar.31 2017) |
02/28/2017 |
Consolidated Fドラクエ 11 カジノancial Results for the 3rd Quarter of the Fiscal Year Endドラクエ 11 カジノg |
02/08/2017 |
Year Endドラクエ 11 カジノg March 31, 2017 Results of 3rd Quarter Settlement of Accounts Supplementary Material (Apr.1 to Dec.31 |